REPORTING OF MEDICATION REGIMEN IN APPLIED STUDIES OF PERSONS WITH MENTAL RETARDATION AND ADHD
Salvato in:
CHRISTIAN, L., ET AL., REPORTING OF MEDICATION REGIMEN IN APPLIED STUDIES OF PERSONS WITH MENTAL RETARDATION AND ADHD. Research in Developmental Disabilities, Vol. 18, no. 5 (1997), p. 319-327.
Ref.
62151
Localizzazione:
SIIS R.775
Palabras clave:
Discapacidad, Discapacidad intelectual, Fármacos, Hiperactividad, Literatura científica, Trastornos de la conducta, Tratamiento, Utilización de servicios
Discapacidad, Discapacidad intelectual, Fármacos, Hiperactividad, Literatura científica, Trastornos de la conducta, Tratamiento, Utilización de servicios
Documenti analoghi: REPORTING OF MEDICATION REGIMEN IN APPLIED STUDIES OF PERSONS WITH MENTAL RETARDATION AND ADHD
- EFFECTS AND NONEFFECTS OF METHYLPHENIDATE IN CHILDREN WITH MENTAL RETARDATION AND ADHD
- PREDICTION OF RESPONSE TO METHYLPHENIDATE AMONG CHILDREN WITH ADHD AND MENTAL RETARDATION
- PREDICTION OF RESPONSE TO METHYLPHENIDATE AMONG CHILDREN WITH ADHD AND MENTAL RETARDATION
- FENFLURAMINE AND METHYLPHENIDATE IN CHILDREN WITH MENTAL RETARDATION AND ADHD: CLINICAL AND SIDE EFFECTS
- LONG-TERM FOLLOW-UP OF CHILDREN WITH MENTAL RETARDATION-BORDELINE INTELLECTUAL FUNCTIONING AND ADHD
- PSYCHOTROPIC MEDICATION FOR ADHD